Literature DB >> 31177014

Virome and bacteriome: two sides of the same coin.

Jonathan Stern1, George Miller2, Xin Li1, Deepak Saxena3.   

Abstract

Although bacterial dysbiosis has been previously associated with carcinogenesis and HIV infection, the impact of the virome and these disease states has been less well studied. In this review, we will summarize what is known about the interplay between both the bacterial and the viral components of the microbiome on cancer and HIV pathogenesis. Bacterial dysbiosis has been associated with carcinogenesis such as colorectal cancer (CRC), hepatocellular carcinoma (HCC), lung cancer, breast cancer, and gastric cancer. The dysbiotic pathogenesis may be species-based or community-based and can have varying mechanisms of carcinogenesis. The human virome was also associated with certain cancers. Viruses, such as cytomegalovirus (CMV), Human herpesvirus 8 (HHV-8), human papilloma virus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV), and Epstein-Barr virus (EBV), all had associations with cancers. It was also reported that an altered bacteriophage community may lead to carcinogenesis by allowing opportunistic, oncogenic bacteria to proliferate in a gastrointestinal biofilm. This mechanism shows the importance of analyzing the bacteriome and the virome concurrently as their interactions can provide insight into new mechanisms in the pathogenesis of not only cancer, but other diseases as well. The enteric bacteriome was shown to be distinctly altered in immunocompromised HIV-infected individuals, and highly active antiretroviral therapy (HAART) was shown to at least partially reverse the alterations that HIV causes in the bacteriome. Studies have shown that the progression to HIV is associated with changes in the plasma concentration of commensal viruses. HIV also acts synergistically with multiple other viruses, such as HPV, EBV, varicella zoster virus (VZV), and HHV-8. Although it has been shown that HIV infection leads to enteric virome expansion in humans, most of the research on HIV's effect on the virome was conducted in non-human primates, and there is a lack of research on the effect of HAART on the virome. Virome-wide analysis is necessary for identifying novel viral etiologies. There is currently a wealth of information on the bacteriome and its associations with cancer and HIV, but more research should be conducted on the virome's associations and reaction to HAART as well as the bacteriome-virome interactions that may play a major role in pathogenesis and recovery.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31177014      PMCID: PMC6768692          DOI: 10.1016/j.coviro.2019.05.007

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  41 in total

Review 1.  Pancreatic cancer, inflammation, and microbiome.

Authors:  Constantinos P Zambirinis; Smruti Pushalkar; Deepak Saxena; George Miller
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 2.  Human microbiome and HIV/AIDS.

Authors:  Deepak Saxena; Yihong Li; Liying Yang; Zhiheng Pei; Michael Poles; William R Abrams; Daniel Malamud
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

Review 3.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

Review 4.  Microbiome alterations in HIV infection a review.

Authors:  Brett Williams; Alan Landay; Rachel M Presti
Journal:  Cell Microbiol       Date:  2016-05       Impact factor: 3.715

5.  Viral sequences in human cancer.

Authors:  Paul G Cantalupo; Joshua P Katz; James M Pipas
Journal:  Virology       Date:  2017-11-05       Impact factor: 3.616

6.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

7.  Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8.

Authors:  Ahmed S Abdulamir; Rand R Hafidh; Fatimah Abu Bakar
Journal:  Mol Cancer       Date:  2010-09-17       Impact factor: 27.401

8.  Dysbiotic bacteria translocate in progressive SIV infection.

Authors:  Z Klase; A Ortiz; C Deleage; J C Mudd; M Quiñones; E Schwartzman; N R Klatt; L Canary; J D Estes; J M Brenchley
Journal:  Mucosal Immunol       Date:  2015-01-14       Impact factor: 7.313

9.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

10.  Antibiotics suppress colon tumorigenesis through inhibition of aberrant DNA methylation in an azoxymethane and dextran sulfate sodium colitis model.

Authors:  Naoko Hattori; Tohru Niwa; Tatsuya Ishida; Kyosuke Kobayashi; Toshio Imai; Akiko Mori; Kana Kimura; Takeshi Mori; Yukio Asami; Toshikazu Ushijima
Journal:  Cancer Sci       Date:  2018-12-13       Impact factor: 6.716

View more
  17 in total

Review 1.  Tools for Analysis of the Microbiome.

Authors:  Jessica Galloway-Peña; Blake Hanson
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

2.  STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.

Authors:  Nicole A Wilski; Colby Stotesbury; Christina Del Casale; Brian Montoya; Eric Wong; Luis J Sigal; Christopher M Snyder
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

3.  Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer.

Authors:  Renyuan Gao; Yefei Zhu; Cheng Kong; Kai Xia; Hao Li; Yin Zhu; Xiaohui Zhang; Yongqiang Liu; Hui Zhong; Rong Yang; Chunqiu Chen; Nan Qin; Huanlong Qin
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

Review 4.  Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection.

Authors:  Mohammed El-Mowafy; Abdelaziz Elgaml; Mohamed El-Mesery; Salma Sultan; Tamer A E Ahmed; Ahmed I Gomaa; Mahmoud Aly; Walid Mottawea
Journal:  Biology (Basel)       Date:  2021-01-13

5.  Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.

Authors:  Małgorzata Łobocka; Krystyna Dąbrowska; Andrzej Górski
Journal:  BioDrugs       Date:  2021-04-21       Impact factor: 5.807

Review 6.  Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis-what is currently known?

Authors:  Karolina Kaźmierczak-Siedlecka; Agnieszka Daca; Giandomenico Roviello; Martina Catalano; Karol Połom
Journal:  Gastric Cancer       Date:  2021-11-06       Impact factor: 7.370

7.  Epstein-Barr Virus+ B Cells in Breast Cancer Immune Response: A Case Report.

Authors:  Andrea Aran; Vicente Peg; Rosa Maria Rabanal; Cristina Bernadó; Esther Zamora; Elisa Molina; Yago A Arribas; Joaquín Arribas; José Pérez; Carme Roura-Mir; Montserrat Carrascal; Javier Cortés; Mercè Martí
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

Review 8.  Fungi, host immune response, and tumorigenesis.

Authors:  Miar Elaskandrany; Rohin Patel; Mintoo Patel; George Miller; Deepak Saxena; Anjana Saxena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-07-07       Impact factor: 4.871

Review 9.  Urobiome: In Sickness and in Health.

Authors:  Bartosz Wojciuk; Agata Salabura; Bartłomiej Grygorcewicz; Karolina Kędzierska; Kazimierz Ciechanowski; Barbara Dołęgowska
Journal:  Microorganisms       Date:  2019-11-10

10.  CMV Seropositive Status Increases Heparanase SNPs Regulatory Activity, Risk of Acute GVHD and Yield of CD34+ Cell Mobilization.

Authors:  Olga Ostrovsky; Katia Beider; Yan Morgulis; Nira Bloom; Angel Cid-Arregui; Avichai Shimoni; Israel Vlodavsky; Arnon Nagler
Journal:  Cells       Date:  2021-12-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.